NTRA FY 2022 Earnings — Natera, Inc. Revenue & Financial Results | Market Cap Arena

NTRANatera, Inc.

$29B

FY 2022 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$820M+31.1% YoY

Gross Profit

$364M44.4% margin

Operating Income

-$541M-66.0% margin

Net Income

-$548M-66.8% margin

EPS (Diluted)

$-5.57

Cash Flow

Operating Cash Flow

-$432M

Free Cash Flow

-$479M

Stock-Based Comp.

$152M

Balance Sheet

Total Assets

$1.4B

Total Liabilities

$689M

Stockholders' Equity

$706M

Cash & Equivalents

$466M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$820M	$625M	+31.1%
Gross Profit	$364M	$307M	+18.5%
Operating Income	-$541M	-$468M	-15.6%
Net Income	-$548M	-$472M	-16.1%